Modeling Pharmacokinetic Profiles for Assessment of Anti-Cancer Drug on a Microfluidic System
The pharmacokinetic (PK) properties of drug, which include drug absorption and excretion, play an important role in determining the in vivo pharmaceutical activity. However, current in vitro systems that model PK profiles are often limited by the in vivo-like concentration profile of a drug. Herein,...
Main Authors: | Yaqiong Guo, Pengwei Deng, Wenwen Chen, Zhongyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Micromachines |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-666X/11/6/551 |
Similar Items
-
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
by: Noël Zahr, et al.
Published: (2022-12-01) -
Pharmacokinetics and dose response of three different anti-TB drugs in rat (balb/c) infection model of tuberculosis
by: Peyman Mohammadzadeh
Published: (2015-01-01) -
Implementation of Pharmacokinetic and Pharmacodynamic Strategies in Early Research Phases of Drug Discovery and Development at Novartis Institute of Biomedical Research
by: Tove eTuntland, et al.
Published: (2014-07-01) -
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
by: Ahmed A. Abulfathi, et al.
Published: (2021-06-01) -
Optimisation of a Microfluidic Method for the Delivery of a Small Peptide
by: Felicity Y. Han, et al.
Published: (2021-09-01)